Quarterly report [Sections 13 or 15(d)]

Financial Instruments (Tables)

v3.26.1
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2026
Text Block [Abstract]  
Summary of Fair Value Hierarchy of Company's Financial Assets and Financial Liabilities

The following table summarizes the fair value hierarchy for the Company’s financial assets and financial liabilities that are re-measured at their fair values periodically:

 

 

 

As of March 31, 2026

 

As of December 31, 2025

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

Level 1

 

Level 2

 

Level 3

 

Total

Financial assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long term investments

 

$

 

$

 

$

878

 

$

878

 

$

2

 

$

 

$

840

 

$

842

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

$

 

$

 

$

3,726

 

$

3,726

 

$

 

$

 

$

3,407

 

$

3,407

Summary of Changes in Level One and Level Three Financial Assets

The following table summarizes the changes in Level 1 and Level 3 financial assets:

 

 

Financial Assets

 

 

 

4Front Venture Corp.

 

 

The Pharm Stand, LLC

 

 

Island Thyme, LLC

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2025

 

$

2

 

$

125

 

$

715

Additions

 

 

 

 

 

 

Revaluations

 

 

(2)

 

 

 

 

Gain on equity method investments

 

 

 

 

 

 

38

Balance as of March 31, 2026

 

$

 

$

125

 

$

753

Summary of changes in level three financial assets and liabilities

The following table summarizes the changes in the Company's Level 3 financial liabilities:

 

 

 

Financial Liabilities

 

 

 

Contingent Consideration Payable

 

 

 

 

 

 

 

 

Balance as of December 31, 2025

 

$

3,407

Consideration paid

 

 

Revaluations

 

 

319

Balance as of March 31, 2026

 

$

3,726

Summary of Long-term Debt Instruments at Carrying Value and Fair Value

The following table summarizes the Company’s long-term debt instruments (Note 5) at their carrying value and fair value:

 

 

As of March 31, 2026

 

As of December 31, 2025

 

 

Carrying Value

 

Fair Value

 

Carrying Value

 

Fair Value

June Unsecured Debentures

 

$

25,657

 

$

24,747

 

$

24,855

 

$

23,831

June Secured Debentures

 

 

164,859

 

 

159,471

 

 

160,772

 

 

154,569

Secured Notes

 

 

8,215

 

 

8,111

 

 

8,359

 

 

8,089

Total

 

$

198,731

 

$

192,329

 

$

193,986

 

$

186,489